Alvogen Group

Alvotech is a biopharmaceutical company that specializes in the development and manufacture of biosimilar medicines aimed at treating severe and chronic conditions. Founded in 2013 and headquartered in Reykjavík, Iceland, with additional facilities in Germany and Switzerland, Alvotech focuses on creating biosimilar versions of leading monoclonal antibodies. The company has six key biosimilar molecules in its development pipeline and has invested over $500 million in this endeavor. Alvotech aims to enhance patient access to effective treatments and improve the overall quality of life for individuals facing various health challenges. In pursuit of its goals, Alvotech has established strategic partnerships with prominent global pharmaceutical companies to facilitate the commercialization of its products.

Kerecis is developing the Kerecis Omega3 fish skin graft technology for use in products to treat chronic wounds, for hernia repair, breast reconstruction and abdominal wall reconstruction. their patented acellular fish skin material improves upon current human and porcine technologies through improved economics and clinical performance, reduced disease transfer risk and absence of cultural constraints on usage.

Omega Bittner is a pharmaceutical company based in Moscow, Russia, established in 1987. It specializes in the distribution of a targeted portfolio of over-the-counter medications, with particular emphasis on categories such as women's healthcare and cough and cold treatments. As a subsidiary of Perrigo Company plc, Omega Bittner plays a crucial role in the pharmaceutical market by providing accessible healthcare solutions.

OOO Dolfin is a Moscow-based company that specializes in the manufacture of anti-inflammatory, immunomodulatory, and antiseptic agents aimed at treating infections. As of November 28, 2016, it operates as a subsidiary of Alvogen, Inc. The company focuses on developing products that address various health concerns related to inflammation and infections, contributing to the pharmaceutical landscape in Russia.

County Line Pharmaceuticals was founded in 2007 by a group of pharmaceutical executives with extensive experience in the pharmaceutical industry. This team was formerly employed at Schwarz Pharma Inc. (the US branded product subsidiary for Schwarz Pharma AG) and played key roles in forming and building Kremers Urban, the highly successful and well-respected generic subsidiary of Schwarz Pharma.

Dream Pharma Corp., pharmaceutical company, manufactures prescription and OTC medications in South Korea. It offers tablets, capsules, creams, injections, and powders in the areas of antihistamines, pain, gastrointestinal, respiratory, circulatory, dermatology, anti-obesities, and others; and nutritional dietary supplements. The company exports its products to India and Vietnam; and offers its products through partnerships with pharmaceutical companies in the United States, Asia, and Europe. Dream Pharma Corp. was formerly known as H-Pharm Co., Ltd. and changed its name to Dream Pharma Corp. in January 2005. The company was founded in 1995 and is based in Seoul, South Korea. Dream Pharma Corp. operates as a subsidiary of Hanwha Corp.

LaborMed's initial focus was on building its portfolio of cardiovascular and central nervous systems treatments.